T. Altwegg

Population-based study of breast cancer survival in Cote d'Or (France): prognostic factors and relative survival.

G. Hédelin, P. Arveux, F. Bonnetain, 2008, Annals of oncology : official journal of the European Society for Medical Oncology.

Population-based study of ovarian cancer in Côte d'Or: prognostic factors and trends in relative survival rates over the last 20 years

P. Arveux, F. Bonnetain, L. Arnould, 2010, BMC Cancer.

In breast cancer, are treatments and survival the same whatever a patient's age? A population‐based study over the period 1998–2009

P. Arveux, V. Quipourt, S. Marilier, 2015, Geriatrics & gerontology international.

6 months versus 12 months of adjuvant trastuzumab in early breast cancer (PHARE): final analysis of a multicentre, open-label, phase 3 randomised trial

C. Tournigand, M. Espié, B. Weber, 2019, The Lancet.